Mark Shearman Location
- Newton, MA, US
Mark Shearman Work
- 2022 - now Founder @ Sharp Focus Consulting LLC
- 2023 - 2024 Chief Executive Officer @
- 2021 - 2023 Advisory Board Chair @
- 2021 - 2023 Chief Scientific Officer and Executive Vice-President @
- 2015 - 2021 Chief Scientific Officer @ AGTC (Applied Genetic Technologies Corporation) [now Beacon Therapeutics]
- 2013 - 2015 Senior Vice-President, Global Research and Early Development; Head Neurology Therapeutic Area @
- 2012 - 2012 Vice-President, Global Research and Early Development; Head, Multiple Sclerosis Research Platform. @
- 2009 - 2011 Vice-President, Global Head Parkinson's disease and Alzheimer's disease research; Vice-President, Head @
- 2006 - 2009 Executive Director, Boston @
- 2006 - 2009 Neuroscience Site Lead, Boston @
- 2004 - 2009 Alzheimer's Disease Therapeutic Area Head @
- 2004 - 2005 Senior Director, Merck Sharp and Dohme Research Laboratories @
Mark Shearman Education
- Kobe University School of Medicine, Dept. of Biochemistry, Kobe, Japan
- Max Planck Institute, Dept. of Molecular Biology, Munich, Germany
Post-Doctoral Fellow, Laboratory of Professor Axel Ullrich (c-KIT Receptor Tyrosine Kinase signal transduction)
- University of Bristol
B.Sc. (Hons) (Biochemistry)
- University of Nottingham
Mark Shearman Skills
- Drug Discovery
- Neuroscience
- Pharmacology
- Alzheimer's disease
- Drug Development
- Science
- Clinical Development
- Lifesciences
- Pharmaceutical Industry
- Biotechnology
- In Vivo
- Clinical Research
- Biochemistry
- Translational Research
- Life Sciences
- Biomarkers
- R&D
- Research
- Cell Culture
- Neurology
- Translational Medicine
- Drug Discovery & Development
- Parkinson's disease
- Business Development
- Pharmaceuticals
- Multiple Sclerosis
- Biopharmaceuticals
- Customer Service
- Molecular Biology
- SQL
- Strategic Planning
- Drug Discovery and Development
- Microsoft Excel
- Strategy
- Data Analysis
Mark Shearman Summary
- Mark Shearman, based in Newton, MA, US, is currently a Founder at Sharp Focus Consulting LLC. Mark Shearman brings experience from previous roles at APRINOIA Therapeutics, Editas Medicine and AGTC (Applied Genetic Technologies Corporation) [now Beacon Therapeutics]. Mark Shearman holds a Kobe University School of Medicine, Dept. of Biochemistry, Kobe, Japan. With a robust skill set that includes Drug Discovery, Neuroscience, Pharmacology, Alzheimer's disease, Drug Development and more. Mark Shearman has 1 mobile phone numbers on RocketReach.
5 free lookup(s).
No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
Looking for a different Mark Shearman?
Find contact details for 700 million professionals.
Others Named Mark Shearman
Mark Shearman
Founder
Newton, MA, US
Mark Shearman
Consultant
Brisbane, QLD, AU
Mark Shearman
Audit Trainee
County Dublin, Ireland
Mark Shearman
Senior Project Manager
St. Peters, MO, US
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups. 
Search the #1 Contact Database
Get contact details of over 700M profiles across 60M companies - all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension. 
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API. 
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co